IMMUNOLOGY2026™: Day 2

In this special episode of The Immunology Podcast, Dr. Jason Goldsmith and Dr. Brenda Roud recap the most compelling science from Day 2 of the 2026 American Association of Immunologists (AAI) meeting in Boston. The hosts highlight groundbreaking research on the microbiome's role in immune regulation, including Fusobacterium's link to colon cancer, Pseudomonas in adipose tissue driving inflammation in obesity, and the surprising influence of skin microbiota on gut immunity in ICI colitis. They delve into novel techniques like GOAT-Seq for probing lectin-carbohydrate interactions and discuss how environmental toxins like dioxin alter microbial glycosylation, disproportionately affecting women. A standout theme is early-life immunology, with talks on maternal-fetal immune partnerships, where metabolites like indole-3-propionate (IPA) from maternal infection confer antiviral protection to neonates, and IgG in breast milk modulating infant immune responses to commensal bacteria. The episode closes with a reflective discussion on the growing burden of data in immunology publications, as highlighted by Ulrich von Andrian’s presidential address, warning of an 'exponential curve' in paper complexity that risks overwhelming the field. The hosts emphasize the need for more thoughtful, sustainable scientific communication. Key takeaways include: (1) The microbiome is not just about which bacteria are present, but how their surface sugars interact with host lectins; (2) Maternal immune signals—via metabolites and IgG—can shape infant immunity long before birth; (3) Environmental toxins like dioxin may disrupt immune function by altering microbial glycosylation; (4) The field must confront the 'data inflation' in publications to maintain scientific integrity; (5) Immune cell identity is more complex than previously thought, with hybrid populations like TETIS cells playing critical roles in regulatory T-cell development. The episode ends with a lighthearted nod to emerging tools like llama antibodies and shark nanobodies, underscoring the field’s innovation.